Orange Book product · Generic (ANDA)
MEROPENEM
MEROPENEM
At a glance
Oct 26, 2011
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 26, 2011
14 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
MEROPENEM
Strength
1GM/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 091404
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of MEROPENEM
- 2023MEROPENEMBrand (NDA)
NDA 215212 · HQ SPCLT PHARMA
- 2015MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINERBrand (NDA)
NDA 202106 · B BRAUN MEDICAL
- 1996MERREM IVBrand (NDA)
NDA 050706 · PFIZER
- 2025MEROPENEMGeneric (ANDA)
ANDA 219084 · BROOKS STERISCIENCE
- 2024MEROPENEMGeneric (ANDA)
ANDA 216424 · QILU
- 2022MEROPENEMGeneric (ANDA)
ANDA 216154 · BROOKS STERISCIENCE
- 2019MEROPENEMGeneric (ANDA)
ANDA 210773 · HQ SPCLT PHARMA
- 2017MEROPENEMGeneric (ANDA)
ANDA 205835 · EUGIA PHARMA
- 2016MEROPENEMGeneric (ANDA)
ANDA 204139 · ACS DOBFAR SPA
- 2016MEROPENEMGeneric (ANDA)
ANDA 206141 · GLAND
- 2016MEROPENEMGeneric (ANDA)
ANDA 206086 · SAVIOR LIFETEC CORP
- 2016MEROPENEMGeneric (ANDA)
ANDA 205883 · AMNEAL PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
